• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在先前接受氟达拉滨治疗的患者自体移植后,与类固醇治疗相关的致命性巨细胞病毒肺炎。

Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine.

作者信息

Grigg A, Chapman R, Szer J

机构信息

Department of Clinical Haematology and Medical Oncology, Royal Melbourne Hospital, Victoria, Australia.

出版信息

Bone Marrow Transplant. 1998 Mar;21(6):619-21. doi: 10.1038/sj.bmt.1701126.

DOI:10.1038/sj.bmt.1701126
PMID:9543067
Abstract

Fludarabine has been associated with an increased risk of opportunistic infections, possibly related to the induction of profound CD4+ lymphopenia. We observed two cases of cytomegalovirus pneumonia (CMV-IP) in a total of nine patients over a 5-year period who had previously received fludarabine and who proceeded to autografting. Both patients also received steroids post-transplant. CMV-IP was observed in one of 104 other autograft recipients over this time who had not received prior fludarabine. This observation suggests that the combination of fludarabine pre-transplant and steroids post-transplant may increase the risk of invasive CMV disease in autograft recipients.

摘要

氟达拉滨与机会性感染风险增加有关,这可能与诱导严重的CD4+淋巴细胞减少有关。在5年期间,我们在总共9例先前接受过氟达拉滨并进行自体移植的患者中观察到2例巨细胞病毒肺炎(CMV-IP)。两名患者移植后也接受了类固醇治疗。在此期间,在其他104例未接受过氟达拉滨的自体移植受者中,有1例观察到CMV-IP。这一观察结果表明,移植前使用氟达拉滨和移植后使用类固醇可能会增加自体移植受者发生侵袭性CMV疾病的风险。

相似文献

1
Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine.在先前接受氟达拉滨治疗的患者自体移植后,与类固醇治疗相关的致命性巨细胞病毒肺炎。
Bone Marrow Transplant. 1998 Mar;21(6):619-21. doi: 10.1038/sj.bmt.1701126.
2
Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.采用基于氟达拉滨的低强度预处理方案进行异基因外周血干细胞移植治疗恶性淋巴瘤。
Bone Marrow Transplant. 2000 May;25(10):1021-8. doi: 10.1038/sj.bmt.1702392.
3
Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection.使用定量全血聚合酶链反应(PCR)方法对异基因骨髓移植中的巨细胞病毒(CMV)感染进行筛查:CMV感染潜在风险因素分析。
Bone Marrow Transplant. 2001 Feb;27(3):301-6. doi: 10.1038/sj.bmt.1702778.
4
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease.以氟达拉滨为基础的低强度预处理方案的异基因干细胞移植作为晚期霍奇金淋巴瘤的过继性免疫治疗。
Bone Marrow Transplant. 2000 Sep;26(6):615-20. doi: 10.1038/sj.bmt.1702580.
5
Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin's lymphoma patients receiving autologous hematopoietic stem cell transplantation.利妥昔单抗治疗增加了接受自体造血干细胞移植的非霍奇金淋巴瘤患者移植后的巨细胞病毒并发症。
Ann Hematol. 2008 Apr;87(4):285-9. doi: 10.1007/s00277-007-0397-0. Epub 2007 Oct 18.
6
Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.与预处理方案相关的肠道黏膜损伤增加了异基因骨髓移植后巨细胞病毒疾病的发生率。
Biol Blood Marrow Transplant. 2009 Jun;15(6):679-85. doi: 10.1016/j.bbmt.2009.02.006. Epub 2009 Apr 11.
7
Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients.异基因非清髓性干细胞移植受者中的非细菌感染
Transpl Infect Dis. 2007 Mar;9(1):3-10. doi: 10.1111/j.1399-3062.2006.00172.x.
8
Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.氟达拉滨序贯环磷酰胺、米托蒽醌、长春新碱及泼尼松治疗低度滤泡性淋巴瘤的II期试验
Am J Hematol. 2002 Jul;70(3):181-5. doi: 10.1002/ajh.10137.
9
Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients.成年自体血液和骨髓移植受者的巨细胞病毒肺炎
Bone Marrow Transplant. 2001 Apr;27(8):877-81. doi: 10.1038/sj.bmt.1702877.
10
Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia.通过定量PCR和pp65抗原血症评估的异基因造血干细胞移植受者在减低剂量预处理或清髓性预处理后的巨细胞病毒感染情况。
Bone Marrow Transplant. 2003 Oct;32(7):695-701. doi: 10.1038/sj.bmt.1704164.

引用本文的文献

1
CMV-specific immune reconstitution following allogeneic stem cell transplantation.异基因造血干细胞移植后的巨细胞病毒特异性免疫重建。
Virulence. 2016 Nov 16;7(8):967-980. doi: 10.1080/21505594.2016.1221022. Epub 2016 Aug 9.